Literature DB >> 80443

Isolation and purification of a polymeric form of the glycoprotein of rabies virus.

B Dietzschold, J H Cox, L G Schneider, T J Wiktor, H Koprowski.   

Abstract

Of the three major proteins associated with the rabies virus membrane, only the glycoprotein was found to be located on the external surface of the virus membrane. Glycoprotein prepared by treatment of rabies virus with Triton X-100 and purified by isoelectric focusing was found to be homogeneous with respect to size and isoelectric point. This material, which is free of phospholipids, is able to protect in vaccination experiments against a lethal challenge infection with rabies virus. The apparent mol. wt. of this component isolated under non-denaturing conditions is approx. 400000. The same material analysed by SDS polyacrylamide gel electrophoresis (PAGE) was found to consist solely of polypeptide chains of the G protein (mol. wt. 80000). A minor glycoprotein (gp 50), detected by PAGE of the Triton X-100 released material, appeared to be a breakdown product of the G-protein. Therefore the detergent released material represents homopolymers of the G-protein. Whether the antigenic determinants reside on the monomeric subunit or are a property of the polymeric form of the G-protein is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 80443     DOI: 10.1099/0022-1317-40-1-131

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine.

Authors:  B Dietzschold; M Gore; D Marchadier; H S Niu; H M Bunschoten; L Otvos; W H Wunner; H C Ertl; A D Osterhaus; H Koprowski
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

2.  Targeted single-neuron infection with rabies virus for transneuronal multisynaptic tracing.

Authors:  Tuan D Nguyen; Christoph Wirblich; Elias Aizenman; Matthias J Schnell; Peter L Strick; Karl Kandler
Journal:  J Neurosci Methods       Date:  2012-06-26       Impact factor: 2.390

3.  Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein.

Authors:  B Dietzschold; H H Wang; C E Rupprecht; E Celis; M Tollis; H Ertl; E Heber-Katz; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Primary structure of leader RNA and nucleoprotein genes of the rabies genome: segmented homology with VSV.

Authors:  N Tordo; O Poch; A Ermine; G Keith
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

5.  Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine.

Authors:  Z F Fu; B Dietzschold; C L Schumacher; W H Wunner; H C Ertl; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

6.  Characterization of saturable binding sites for rabies virus.

Authors:  W H Wunner; K J Reagan; H Koprowski
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

7.  Biological characterization of human monoclonal antibodies to rabies virus.

Authors:  B Dietzschold; M Gore; P Casali; Y Ueki; C E Rupprecht; A L Notkins; H Koprowski
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  A recombinant human Fab expressed in Escherichia coli neutralizes rabies virus.

Authors:  S C Cheung; B Dietzschold; H Koprowski; A L Notkins; R F Rando
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

9.  Preparation and characterization of rabies virus hemagglutinin.

Authors:  J H Cox; B Dietzschold; F Weiland; L G Schneider
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

10.  Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients.

Authors:  E Celis; D Ou; B Dietzschold; H Koprowski
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.